Published in J Virol on April 01, 1985
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol (1985) 2.58
Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. Proc Natl Acad Sci U S A (1986) 2.36
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. J Virol (1990) 2.17
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. J Virol (1986) 1.78
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Mol Cell Biol (1990) 1.66
Identification of three forms of human myelin basic protein by cDNA cloning. Proc Natl Acad Sci U S A (1986) 1.64
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J Virol (1997) 1.41
Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J Cell Biol (1986) 1.36
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. J Virol (1991) 1.24
Structure and function of bicistronic RNA encoding the phosphoprotein and matrix protein of measles virus. J Virol (1987) 1.09
Characterization of V protein in measles virus-infected cells. J Virol (1991) 1.06
Involvement of the C-terminus of the inositol 1,4,5-trisphosphate receptor in Ca2+ release analysed using region-specific monoclonal antibodies. Biochem J (1991) 1.03
Cell surface expression of glycosylated, nonglycosylated, and truncated forms of a cytoplasmic protein pyruvate kinase. J Cell Biol (1988) 1.02
Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J Virol (1991) 1.02
High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system. J Virol (1988) 0.97
Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors. J Virol (1994) 0.96
Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein. J Virol (2004) 0.92
Identification and characterization of a baculovirus occlusion body glycoprotein which resembles spheroidin, an entomopoxvirus protein. J Virol (1990) 0.91
Selective inhibition of translation of the mRNA coding for measles virus membrane protein at elevated temperatures. J Virol (1987) 0.88
Protein sorting between mitochondrial membranes specified by position of the stop-transfer domain. J Cell Biol (1988) 0.85
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Immunogenic structure of the influenza virus hemagglutinin. Cell (1982) 8.93
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32
Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature (1982) 5.11
Antigenic structure of myoglobin: the complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins. Immunochemistry (1975) 4.90
Sendai virus contains overlapping genes expressed from a single mRNA. Cell (1983) 4.71
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35
Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell (1982) 3.07
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Complete sequences of the intergenic and mRNA start signals in the Sendai virus genome: homologies with the genome of vesicular stomatitis virus. Nucleic Acids Res (1984) 2.45
Structure of the gene N:gene NS intercistronic junction in the genome of vesicular stomatitis virus. Cell (1979) 2.37
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Antibodies that react with predetermined sites on proteins. Science (1983) 1.87
In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses. Virology (1980) 1.78
Molecular cloning of the 3'-proximal third of Sendai virus genome. Proc Natl Acad Sci U S A (1983) 1.73
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
Coding assignments of the five smaller mRNAs of Newcastle disease virus. J Virol (1982) 1.67
Measles virus polypeptides synthesis in infected cells. Virology (1978) 1.61
Sequence homology within the morbilliviruses. J Virol (1985) 1.56
Antibodies to chemically synthesized peptides predicted from DNA sequences as probes of gene expression. Cell (1981) 1.52
Chemically defined antiviral vaccines. Annu Rev Microbiol (1980) 1.41
Synthetic peptide fragment of src gene product inhibits the src protein kinase and crossreacts immunologically with avian onc kinases and cellular phosphoproteins. Proc Natl Acad Sci U S A (1981) 1.39
Synthetic peptide immunogens as vaccines. Annu Rev Microbiol (1983) 1.39
Human adenovirus 2 E1B-19K and E1B-53K tumor antigens: antipeptide antibodies targeted to the NH2 and COOH termini. J Virol (1983) 1.38
Cloning of DNA corresponding to four different measles virus genomic regions. Virology (1984) 1.38
Construction and characterization of cDNA clones for four respiratory syncytial viral genes. Proc Natl Acad Sci U S A (1983) 1.35
Cloning and characterization of DNA complementary to the measles virus mRNA encoding hemagglutinin and matrix protein. J Virol (1982) 1.32
Nucleotide sequence of the gene encoding respiratory syncytial virus matrix protein. J Virol (1984) 1.31
In vitro synthesis of the nonstructural C protein of Sendai virus. J Virol (1983) 1.29
Structural and functional characterization of Newcastle disease virus polycistronic RNA species. J Virol (1984) 1.28
Respiratory syncytial virus mRNA coding assignments. J Virol (1983) 1.28
Isolation and characterization of measles virus intracellular nucleocapsid RNA. J Virol (1984) 1.18
Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11
Polypeptide synthesis i mumps virus-infected cells. J Gen Virol (1980) 1.10
Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1983) 1.05
Developing synthetic vaccines. Nature (1982) 0.96
Antibodies against a nonapeptide of polyomavirus middle T antigen: cross-reaction with a cellular protein(s). J Virol (1983) 0.95
Effect of undiluted passage on the polypeptides of measles virus. J Gen Virol (1979) 0.90
Purification and molecular weight determination of measles virus genomic RNA. J Gen Virol (1983) 0.86
Synthetic vaccines. Sci Am (1983) 0.80
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell (1993) 7.71
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44
Simian virus 40 DNA directs synthesis of authentic viral polypeptides in a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1975) 4.98
Universal GFP reporter for the study of vascular development. Genesis (2000) 3.97
Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology (1995) 3.87
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Infectious viral DNA of murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.09
Cell-free translation of messenger RNA of simian virus 40: synthesis of the major capsid protein. Proc Natl Acad Sci U S A (1974) 3.04
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol (1985) 2.58
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature (2001) 2.47
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res (1995) 2.33
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes. Infect Immun (1989) 2.22
Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology (2004) 2.18
Direct biochemical mapping of eukaryotic viral DNA by means of a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1976) 2.17
Expression of the gene encoding the 17-kilodalton antigen from Rickettsia rickettsii: transcription and posttranslational modification. J Bacteriol (1988) 2.14
The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology (1998) 2.13
Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology (1983) 2.00
Entamoeba histolytica ribosomal RNA genes are carried on palindromic circular DNA molecules. Mol Biochem Parasitol (1989) 1.92
Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87
Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83
CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology (2001) 1.78
The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology (1986) 1.76
Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation (1999) 1.76
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61
Sequence homology within the morbilliviruses. J Virol (1985) 1.56
Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis (1997) 1.56
Alpha2-adrenergic receptors in human dorsal root ganglia: predominance of alpha2b and alpha2c subtype mRNAs. Anesthesiology (2000) 1.55
Cloning of DNA complementary to the measles virus mRNA encoding nucleocapsid protein. Proc Natl Acad Sci U S A (1980) 1.50
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47
Covalently linked cell and SV40-specific sequences in an RNA from productively infected cells. Virology (1972) 1.46
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology (2000) 1.46
Separation and quantitation of intracellular forms of poliovirus RNA by agarose gel electrophoresis. Biochemistry (1977) 1.43
New genetic group of measles virus isolated in the People's Republic of China. Virus Res (1998) 1.42
Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J Virol (1997) 1.41
Molecular epidemiology of measles virus. Curr Top Microbiol Immunol (2009) 1.41
Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol (2000) 1.39
Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol (1999) 1.38
Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36
Cloning and characterization of DNA complementary to the measles virus mRNA encoding hemagglutinin and matrix protein. J Virol (1982) 1.32
Acquisition of sequences homologous to host DNA by closed circular simian virus 40 DNA. 3. Host sequences. J Virol (1973) 1.32
Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol (1993) 1.31
Characterization of measles virus-specific proteins synthesized in vivo and in vitro from acutely and persistently infected cells. J Virol (1979) 1.31
Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology (1994) 1.31
Functional and structural interactions between measles virus hemagglutinin and CD46. J Virol (1995) 1.29
Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med (1985) 1.29
X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev (2001) 1.27
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem (2000) 1.26
Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology (1991) 1.26
Acquisition of sequences homologous to host DNA by closed circular simian virus 40 DNA. II. Further studies on the serial passage of virus clones. J Virol (1973) 1.25
Entamoeba histolytica: cloning and characterization of actin cDNA. Mol Biochem Parasitol (1987) 1.25
Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol (1995) 1.19
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol (1986) 1.18
Alpha1-adrenergic receptor subtypes in human detrusor. J Urol (1998) 1.18
Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res (2001) 1.18
The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol (1995) 1.18
Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14
Bee sting-induced ocular changes. Ann Ophthalmol (1986) 1.13
Infective substructures of measles virus from acutely and persistently infected cells. J Virol (1979) 1.13
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Virology (1998) 1.10
The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol (1997) 1.08
Measles virus strain variations. Curr Top Microbiol Immunol (1995) 1.08
Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08
Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07
Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06
Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis (1993) 1.05
Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. JAMA (1996) 1.05
Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis (1994) 1.05
5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem (1993) 1.05
Nucleotide sequence analysis of an Entamoeba histolytica ferredoxin gene. Mol Biochem Parasitol (1988) 1.04
Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol (2014) 1.03
Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis (1999) 1.03